Phonophoresis and the absorption of dexamethasone in the presence of an occlusive dressing

Journal of Athletic Training

Volumn 42, Issue 3, 2007, Pages 349-354

  Saliba, Susan ^a   Mistry, Dilaawar J ^a   Perrin, David H ^a   Gieck, Joe ^a   Weltman, Arthur ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Skin saturation; Therapeutic ultrasound; Ultrasound

Indexed keywords

DEXAMETHASONE;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; CONTROLLED STUDY; CREAM; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SKIN ABSORPTION; ULTRASOUND; WOUND DRESSING;

ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFLAMMATORY AGENTS; CROSS-OVER STUDIES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; OCCLUSIVE DRESSINGS; PHONOPHORESIS; SKIN ABSORPTION; TREATMENT OUTCOME;

EID: 35148854660     PISSN: 10626050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kleinkort JA, Wood F. Phonophoresis with 1 percent versus 10 percent hydrocortisone. Phys Ther. 1975;55:1320-1324.
2. Davick JP, Martin RK, Albright JP. Distribution and deposition of tritiated cortisol using phonophoresis. Phys Ther. 1988;68:1672-1675.
3. Stratford PW, Levy DR, Gauldie S, Miseferi D, Levy K. The evaluation of phonophoresis and friction massage as treatments for extensor carpi radialis tendinitis: a randomized controlled trial. Physiother Can. 1989;41:93-99.
4. Byl NN, McKenzie AL, Halliday B, Wong T, O'Connell J. The effects of phonophoresis with corticosteroids: a controlled pilot study. J Orthop Sports Phys Ther. 1993;18:590-600.
5. Bare AC, McAnaw MB, Pritchard AE, et al. Phonophoretic delivery of 10% hydrocortisone through the epidermis of humans as determined by serum cortisol concentrations. Phys Ther. 1996;76:738-749.
6. Kuntz AR, Griffiths CM, Rankin JM, Armstrong CW, McLoughlin TL. Cortisol concentrations in human skeletal muscle tissue after phonophoresis with 10% hydrocortisone gel. J Athl Train. 2006;41:321-324.
7. Benson HA, McElnay JC, Harland R. Use of ultrasound to enhance percutaneous absorption of benzydamine. Phys Ther. 1989;69:113-118.
8. Moll M. A new approach to pain: lidocaine and decadron with ultrasound. USAF Med Serv Dig. 1979;30:8-10.
9. Franklin ME, Smith ST, Chenier TC, Franklin RC. Effect of phonophoresis with dexamethasone on adrenal function. J Orthop Sports Phys Ther. 1995;22:103-107.
10. Darrow H, Schulthies S, Draper D, Ricard M, Measom GJ. Serum dexamethasone levels after Decadron phonophoresis. J Athl Train. 1999;34:338-341.
11. Ciccone CD, Leggin BG, Callamaro JJ. Effects of ultrasound and trolamine salicylate phonophoresis on delayed-onset muscle soreness. Phys Ther. 1991;71:666-678.
12. Oziomek RS, Perrin DH, Herold DA, Denegar CR. Effect of phonophoresis on serum salicylate levels. Med Sci Sports Exerc. 1991;23:397-401.
13. Baldwin JR, Carrano RA, Imondi AR. Penetration of trolamine salicylate into the skeletal muscle of the pig. J Pharm Sci. 1984;73:1002-1004.
14. Hill DW, Richardson JD. Effectiveness of 10% trolamine salicylate cream on muscular soreness induced by a reproducible program of weight training. J Orthop Sports Phys Ther. 1989;11:19-23.
15. Novak EJ. Experimental transmission of lidocaine through intact skin by ultrasound. Arch Phys Med Rehabil. 1964;45:231-232.
16. Benson HAE, McElnay JC, Harland R. Phonophoresis of lignocaine and prilocaine from EMLA cream. Int J Pharm. 1988;44:65-69.
17. McElnay JC, Matthews MP, Harland R, McCafferty DF. The effect of ultrasound on the percutaneous absorption of lignocaine. Br J Clin Pharmacol. 1985;20:421-424.
18. Mendez J, Franklin B, Kollias J. Effect of ultrasound on the permeability of D2O through cellulose membranes. Biomedicine. 1976;25:121-122.
19. Lenart I, Ausländer D. The effect of ultrasound on diffusion through membranes. Ultrasonics. 1980;18:216-218.
20. Halle JS, Franklin RJ, Kralfa BL. Comparison of four treatment approaches for lateral epicondylitis of the elbow. J Orthop Sports Phys Ther. 1986;8:62-68.
21. Holdsworth LK, Anderson DM. Effectiveness of ultrasound used with a hydrocortisone coupling medium or epicondylitis clasp to treat lateral epicondylitis: pilot study. Physiotherapy. 1993;79:19-25.
22. Wing M. Phonophoresis with hydrocortisone in the treatment of temporomandibular joint dysfunction. Phys Ther. 1982;62:32-33.
23. Griffin JE, Echternach JL, Price RE, Touchstone JC. Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. Phys Ther. 1967;47:594-601.
24. Pottenger FJ, Karalfa BL. Utilization of hydrocortisone phonophoresis in United States Army physical therapy clinics. Mil Med. 1989;154:355-358.
25. Quillen W. Phonophoresis: a review of the literature and technique. Athl Train. 1980;15:109-110.
26. Bommannan D, Okuyama H, Stauffer P, Guy RH. Sonophoresis, I: the use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res. 1992;9:559-564.
27. Bommannan D, Menon GK, Okuyama H, Elias PM, Guy RH. Sonophoresis, II: examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res. 1992;9:1043-1047.
28. Feldman RJ, Maibach HI. Penetration of 14C-hydrocortisone through normal skin. Arch Dermatol. 1965;91:661-666.
29. Evers H, von Dardel O, Juhlin L, Ohlsen L, Vinnars E. Dermal effects of compositions based on the eutectic mixture of lignocaine and prilocaine (EMLA): studies in volunteers. Br J Anaesth. 1985;57:997-1005.
30. Brown L, Langer R. Transdermal delivery of drugs. Annu Rev Med. 1988;39:221-229.
31. Schwandt RE, Hayes JM. Clinical overview of topical corticosteroids. Available at: http://www.helix.com/helix/resc/trends/pharmacy/aug96_ce.htm. Accessed June 13, 2002.
32. Griffin JE, Touchstone JC. Ultrasonic movement of cortisol into pig tissues, I: movement into skeletal muscle. Am J Phys Med. 1963;42:77-85.
33. Dyson M. Mechanisms involved in therapeutic ultrasound. Physiotherapy. 1987;73:116-120.
34. ter Haar G, Dyson M, Oakley EM. The use of ultrasound by physiotherapists in Britain, 1985. Ultrasound Med Biol. 1987;13:659-663.
35. Mitragotri S, Farrell J, Tang H, Terahara T, Kost J, Langer R. Determination of threshold energy dose for ultrasound-induced transdermal drug transport. J Control Release. 2000;63:41-52.
36. Caldarella AM, Reardon GE, Canalis E. Analysis for cortisol in serum by liquid chromatography. Clin Chem. 1982;28:538-543.
37. Draper DO, Castel JC, Castel D. Rate of temperature increase in human muscle during 1 MHz and 3 MHz continuous ultrasound. J Orthop Sports Phys Ther. 1995;22:142-150.
38. Draper DO, Ricard MD. Rate of temperature decay in human muscle following 3 MHz ultrasound: the stretching window revealed. J Athl Train. 1995;30:304-307.
39. Gallo JA, Draper DO, Brody LT, Fellingham GW. A comparison of human muscle temperature increases during 3-MHz continuous and pulsed ultrasound with equivalent temporal average intensities. J Orthop Sports Phys Ther. 2004;34:395-401.
40. Michlovitz SL. Is there a role for ultrasound and electrical stimulation following injury to tendon and nerve? J Hand Ther. 2005;18:292-296.
41. Chien YW, Liu JC. Transdermal drug delivery systems. J Biomater Appl. 1986;1:183-206.
42. Reed JT, Ghadially R, Elias PM. Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol. 1995;131:1134-1138.
43. McNeill SC, Potts RO, Francoeur ML. Local enhanced topical delivery (LETD) of drugs: does it truly exist? Pharm Res. 1992;9:1422-1427.